NeoGenomics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $172,000 | $167,824 | $164,502 | $156,240 |
Gross Profit | 77,257 | 74,880 | 69,042 | 62,017 |
EBITDA | 3,684 | 1,778 | 756 | -7,729 |
EBIT | -14,504 | -16,207 | -17,351 | -25,996 |
Net Income | -15,324 | -17,699 | -18,642 | -27,061 |
Net Change In Cash | 172,000 | 167,824 | 164,502 | 156,240 |
Free Cash Flow | -1,799 | -1,553 | 814 | -31,500 |
Cash | 367,012 | 361,992 | 355,085 | 331,914 |
Basic Shares | 127,160 | 126,953 | 126,405 | 126,111 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $660,566 | $591,643 | $509,728 | $484,329 |
Gross Profit | 290,100 | 244,604 | 187,896 | 187,060 |
EBITDA | -1,511 | -17,607 | -78,631 | 52,075 |
EBIT | -74,058 | -90,190 | -157,836 | -9,993 |
Net Income | -78,726 | -87,968 | -144,250 | -8,347 |
Net Change In Cash | 660,566 | 591,643 | 509,728 | 484,329 |
Cost of Revenue | -53,647 | 66,195 | ||
Free Cash Flow | -34,038 | -30,705 | -96,884 | -90,865 |
Cash | 367,012 | 342,488 | 263,180 | 316,827 |
Basic Shares | 126,658 | 125,502 | 124,217 | 119,962 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.04 |
2024-09-30 | -$0.13 |
2024-06-30 | $0.03 |
2024-03-31 | -$0.02 |
